How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Daniel Raskas Biography and Net Worth

SVP of Danaher

As Senior Vice President, Corporate Development, Daniel Raskas leads mergers and acquisitions in partnership with Bill King and oversees investment activity, including identification, valuation, due diligence, contract strategy and negotiations.

Daniel joined Danaher in 2004, originally serving as Vice President of Corporate Development, and was promoted to his current role in 2010. Throughout his tenure, he has led business development across the company and overseen a number of major acquisitions, including Beckman Coulter, Pall and Cytiva.

Before joining Danaher, Daniel was a partner at Thayer Capital Partners, a private equity firm focused on buyout and growth equity investments in the middle market. He also served as an associate at Arnold & Porter LLP for several years, where he specialized in transactional work including M&A and public offerings.

Daniel received a B.A. in Government from Harvard College, an M.B.A. from Columbia University School of International and Public Affairs, and a J.D. from Harvard Law School.

What is Daniel Raskas' net worth?: The estimated net worth of Daniel Raskas is at least $8.33 million as of July 28th, 2023. Mr. Raskas owns 38,288 shares of Danaher stock worth more than $8,327,257 as of December 11th. This net worth approximation does not reflect any other investments that Mr. Raskas may own. Learn More about Daniel Raskas' net worth.
How old is Daniel Raskas?: Mr. Raskas is currently 56 years old. There are 6 older executives and no younger executives at Danaher. The oldest executive at Danaher is Mr. Steven M. Rales, Co-Founder & Chairman, who is 72 years old. Learn More on Daniel Raskas' age.
How do I contact Daniel Raskas?: The corporate mailing address for Mr. Raskas and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on Daniel Raskas' contact information.
Has Daniel Raskas been buying or selling shares of Danaher?: Daniel Raskas has not been actively trading shares of Danaher over the course of the past ninety days. Most recently, Daniel Raskas sold 11,213 shares of the business's stock in a transaction on Friday, July 28th. The shares were sold at an average price of $260.65, for a transaction totalling $2,922,668.45. Following the completion of the sale, the senior vice president now directly owns 38,288 shares of the company's stock, valued at $9,979,767.20. Learn More on Daniel Raskas' trading history.
Who are Danaher's active insiders?: Danaher's insider roster includes Rainer Blair (EVP), Daniel Comas (EVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.
Are insiders buying or selling shares of Danaher?: In the last twelve months, insiders at the conglomerate sold shares 11 times. They sold a total of 90,798 shares worth more than $22,878,524.16. The most recent insider tranaction occured on August, 21st when SVP Jose-Carlos Gutierrez-Ramos sold 590 shares worth more than $147,818.60. Insiders at Danaher own 11.1% of the company. Learn More about insider trades at Danaher.
Information on this page was last updated on 8/21/2023.

Daniel Raskas Insider Trading History at Danaher

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/28/2023	Sell	11,213	$260.65	$2,922,668.45	38,288
5/31/2023	Sell	19,847	$228.50	$4,535,039.50	38,673
11/26/2021	Sell	12,300	$325.33	$4,001,559.00
10/23/2020	Sell	28,389	$234.50	$6,657,220.50	38,850
5/8/2020	Sell	37,082	$164.09	$6,084,785.38	19,723
11/16/2017	Sell	37,870	$93.33	$3,534,407.10
2/26/2016	Sell	4,656	$89.00	$414,384.00	17,786
2/26/2015	Sell	4,179	$87.79	$366,874.41
2/20/2015	Sell	56,000	$87.03	$4,873,680.00
5/1/2014	Sell	11,158	$73.48	$819,889.84	18,368
10/18/2013	Sell	20,000	$71.99	$1,439,800.00
7/24/2013	Sell	20,000	$67.54	$1,350,800.00

Daniel Raskas Buying and Selling Activity at Danaher

Danaher Company Overview

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.

Today's Range

Now: $221.35

$217.96

$221.70

50 Day Range

MA: $208.65

$185.10

$223.48

2 Week Range

Now: $221.35

$182.09

$249.59

Volume

2,576,101 shs

Average Volume

3,209,708 shs

Market Capitalization

$163.56 billion

P/E Ratio

27.91

Dividend Yield

0.50%

Beta

0.84

Is This The Most Overlooked Gold Investment Strategy of 2024?

From Edge On The Street | Ad

There is little debate on the potential of gold in the next year and decade. The real issue becomes - what's the best gold investment strategy today? Some investors are opting for a unique "royalty" alternative that outshines other options like holding gold bullion or investing in volatile mining stocks.

Read this stunning report on a little-known gold

Daniel Raskas Biography and Net Worth

What is Daniel Raskas' net worth?

How old is Daniel Raskas?

How do I contact Daniel Raskas?

Has Daniel Raskas been buying or selling shares of Danaher?

Who are Danaher's active insiders?

Are insiders buying or selling shares of Danaher?